- Global phase 2 study will evaluate safety and efficacy of DS-8201 in patients with unresectable and/or metastatic non-squamous HER2-overexpressing or HER2-mutated non-small cell lung cancer - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results